New Insight into the Functioning of Nitric Oxide-receptive Guanylyl Cyclase: Physiological and Pharmacological Implications

Overview

Journal Mol Cell Biochem

Publisher Springer

Specialty Biochemistry

Date 2009 Dec 17

PMID 20012469

Citations 41

Authors

John Garthwaite

Affiliations

Soon will be listed here.

Abstract

The cellular counterpart of the "soluble" guanylyl cyclase found in tissue homogenates over 30 years ago is now recognized as the physiological receptor for nitric oxide (NO). The ligand-binding site is a prosthetic haem group that, when occupied by NO, induces a conformational change in the protein that propagates to the catalytic site, triggering conversion of GTP into cGMP. This review focuses on recent research that takes this basic information forward to the beginnings of a quantitative depiction of NO signal transduction, analogous to that achieved for other major transmitters. At its foundation is an explicit enzyme-linked receptor mechanism for NO-activated guanylyl cyclase that replicates all its main properties. In cells, NO signal transduction is subject to additional, activity-dependent modifications, notably through receptor desensitization and changes in the activity of cGMP-hydrolyzing phosphodiesterases. The measurement of these parameters under varying conditions in rat platelets has made it possible to formulate a cellular model of NO-cGMP signaling. The model helps explain cellular responses to NO and their modification by therapeutic agents acting on the guanylyl cyclase or phosphodiesterase limbs of the pathway.

Citing Articles

NO rapidly mobilizes cellular heme to trigger assembly of its own receptor.

Dai Y, Faul E, Ghosh A, Stuehr D Proc Natl Acad Sci U S A. 2022; 119(4).

PMID: 35046034 PMC: 8795550. DOI: 10.1073/pnas.2115774119.

Maturation, inactivation, and recovery mechanisms of soluble guanylyl cyclase.

Stuehr D, Misra S, Dai Y, Ghosh A J Biol Chem. 2021; 296:100336.

PMID: 33508317 PMC: 7949132. DOI: 10.1016/j.jbc.2021.100336.

Nitric oxide as a multimodal brain transmitter.

Garthwaite J Brain Neurosci Adv. 2020; 2:2398212818810683.

PMID: 32166152 PMC: 7058253. DOI: 10.1177/2398212818810683.

Pharmacological NOS-1 Inhibition Within the Hippocampus Prevented Expression of Cocaine Sensitization: Correlation with Reduced Synaptic Transmission.

de la Villarmois E, Gabach L, Bianconi S, Belen Poretti M, Occhieppo V, Schioth H Mol Neurobiol. 2019; 57(1):450-460.

PMID: 31378002 DOI: 10.1007/s12035-019-01725-3.

Nitric oxide signalling in the brain and its control of bodily functions.

Chachlaki K, Prevot V Br J Pharmacol. 2019; 177(24):5437-5458.

PMID: 31347144 PMC: 7707094. DOI: 10.1111/bph.14800.

References

Nikolaev V, Gambaryan S, Lohse M . Fluorescent sensors for rapid monitoring of intracellular cGMP. Nat Methods. 2005; 3(1):23-5. DOI: 10.1038/nmeth816. View

Mellion B, Ignarro L, Ohlstein E, Pontecorvo E, HYMAN A, Kadowitz P . Evidence for the inhibitory role of guanosine 3', 5'-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood. 1981; 57(5):946-55. View

Franks K, Bartol Jr T, Sejnowski T . A Monte Carlo model reveals independent signaling at central glutamatergic synapses. Biophys J. 2002; 83(5):2333-48. PMC: 1302323. DOI: 10.1016/S0006-3495(02)75248-X. View

Ignarro L . Nitric oxide: a unique endogenous signaling molecule in vascular biology. Biosci Rep. 2000; 19(2):51-71. DOI: 10.1023/a:1020150124721. View

Gibson A . Phosphodiesterase 5 inhibitors and nitrergic transmission-from zaprinast to sildenafil. Eur J Pharmacol. 2001; 411(1-2):1-10. DOI: 10.1016/s0014-2999(00)00824-4. View

Zabel U, Kleinschnitz C, Oh P, Nedvetsky P, Smolenski A, Muller H . Calcium-dependent membrane association sensitizes soluble guanylyl cyclase to nitric oxide. Nat Cell Biol. 2002; 4(4):307-11. DOI: 10.1038/ncb775. View

Ruiz-Stewart I, Tiyyagura S, Lin J, Kazerounian S, Pitari G, Schulz S . Guanylyl cyclase is an ATP sensor coupling nitric oxide signaling to cell metabolism. Proc Natl Acad Sci U S A. 2003; 101(1):37-42. PMC: 314134. DOI: 10.1073/pnas.0305080101. View

Roy B, Mo E, Vernon J, Garthwaite J . Probing the presence of the ligand-binding haem in cellular nitric oxide receptors. Br J Pharmacol. 2008; 153(7):1495-504. PMC: 2437902. DOI: 10.1038/sj.bjp.0707687. View

Venema R, Venema V, Ju H, Harris M, Snead C, Jilling T . Novel complexes of guanylate cyclase with heat shock protein 90 and nitric oxide synthase. Am J Physiol Heart Circ Physiol. 2003; 285(2):H669-78. DOI: 10.1152/ajpheart.01025.2002. View

10.

Galle J, Zabel U, Hubner U, Hatzelmann A, Wagner B, Wanner C . Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity. Br J Pharmacol. 1999; 127(1):195-203. PMC: 1565982. DOI: 10.1038/sj.bjp.0702495. View

11.

Stasch J, Schmidt P, Alonso-Alija C, Apeler H, Dembowsky K, Haerter M . NO- and haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle. Br J Pharmacol. 2002; 136(5):773-83. PMC: 1573403. DOI: 10.1038/sj.bjp.0704778. View

12.

Keynes R, Griffiths C, Garthwaite J . Superoxide-dependent consumption of nitric oxide in biological media may confound in vitro experiments. Biochem J. 2002; 369(Pt 2):399-406. PMC: 1223083. DOI: 10.1042/BJ20020933. View

13.

Corbin J, Blount M, Weeks 2nd J, Beasley A, Kuhn K, Ho Y . [3H]sildenafil binding to phosphodiesterase-5 is specific, kinetically heterogeneous, and stimulated by cGMP. Mol Pharmacol. 2003; 63(6):1364-72. DOI: 10.1124/mol.63.6.1364. View

14.

Bellamy T, Garthwaite J . Sub-second kinetics of the nitric oxide receptor, soluble guanylyl cyclase, in intact cerebellar cells. J Biol Chem. 2000; 276(6):4287-92. DOI: 10.1074/jbc.M006677200. View

15.

Bellamy T, Garthwaite J . Pharmacology of the nitric oxide receptor, soluble guanylyl cyclase, in cerebellar cells. Br J Pharmacol. 2002; 136(1):95-103. PMC: 1762114. DOI: 10.1038/sj.bjp.0704687. View

16.

Papapetropoulos A, Zhou Z, Gerassimou C, Yetik G, Venema R, Roussos C . Interaction between the 90-kDa heat shock protein and soluble guanylyl cyclase: physiological significance and mapping of the domains mediating binding. Mol Pharmacol. 2005; 68(4):1133-41. DOI: 10.1124/mol.105.012682. View

17.

Russwurm M, Wittau N, Koesling D . Guanylyl cyclase/PSD-95 interaction: targeting of the nitric oxide-sensitive alpha2beta1 guanylyl cyclase to synaptic membranes. J Biol Chem. 2001; 276(48):44647-52. DOI: 10.1074/jbc.M105587200. View

18.

Mullershausen F, Russwurm M, Thompson W, Liu L, Koesling D, Friebe A . Rapid nitric oxide-induced desensitization of the cGMP response is caused by increased activity of phosphodiesterase type 5 paralleled by phosphorylation of the enzyme. J Cell Biol. 2001; 155(2):271-8. PMC: 2198829. DOI: 10.1083/jcb.200107001. View

19.

Bernengo J, Collet C, Jacquemond V . Intracellular Mg2+ diffusion within isolated rat skeletal muscle fibers. Biophys Chem. 2001; 89(1):35-51. DOI: 10.1016/s0301-4622(00)00215-5. View

20.

Wykes V, Garthwaite J . Membrane-association and the sensitivity of guanylyl cyclase-coupled receptors to nitric oxide. Br J Pharmacol. 2004; 141(7):1087-90. PMC: 1574895. DOI: 10.1038/sj.bjp.0705745. View